While PET imaging can reveal both total and regional insoluble, fibrillar amyloid and tau accumulation,13 less is known about how CSF Alzheimer’s disease biomarkers,3,14,15 which reflect net production and clearance rates of soluble amyloid and tau species, relate to brain atrophy. The gene discussed is MAPT; the disease is Alzheimer disease.